A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response

John R. Bankston, Minerva Yue, Wendy Chung et al. · 2007

Read A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response by John R. Bankston, Minerva Yue, Wendy Chung et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001258.txt.

Description

Long QT syndrome is an inherited heart rhythm disorder that can kill without warning. John Bankston and colleagues report the case of a newborn carrying a new mutation, in a 2007 PLOS ONE article. The mutation sits in SCN5A, the gene for the heart's main sodium channel, and caused the variant called LQT-3.

The authors describe the de novo mutation as novel and lethal, with distinct molecular pharmacology and a distinct therapeutic response. De novo means it appeared fresh in the child, not inherited. Working out how this channel variant answers to drugs guided treatment of a very young patient.

Catalog record

CREATORJohn R. Bankston, Minerva Yue, Wendy Chung et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001258

Browse the full library · About the Tower of Babel